Cell culture of tumors alters endogenous poly(ADPR)polymerase expression and activity

Publisher Website
Google Scholar
Abstract
Poly(ADP‐ribose)polymerase, a chromatin‐bound enzyme, actively participates in processes such as cell proliferation, differentiation, and DNA repair and replication. This enzyme is also implicated in cell transformation, and its inhibition has been proposed to potentiate anti‐cancer drug activity. Since cells prepared from tumor biopsies and established tumor cell lines are commonly used to evaluate the efficiency of anticancer therapies, we have compared poly(ADP‐ribose)polymerase activity in animal tumor cells growing in vivo and in cell culture. Three tumor types were tested: a mastocytoma (P815), a lymphoma (RDM4). and a glioma (C6). Our results show that cell culture alters poly(ADP‐ribose)polymerase levels and activity. Endogenous poly(ADP‐ribose) activity was several fold higher in exponentially growing cells than in cells freshly recovered from solid or ascitic tumors. Moreover, polymerase activity increased with culture time, reaching a maximum when cells became confluent. Measurements of poly(ADP‐ribose)polymerase gene expression and protein amount indicate that lower enzyme activity in tumors grown in vivo are sustained by decreases in poly(ADP‐ribose)polymerase mRNA and protein amount. In contrast, the increase in endogenous poly(ADP‐ribose)polymerase activity observed in cultured cells was due to enzyme activation and not to de novo protein synthesis. Such differences must be considered when assessing the applicability of cell‐culture results to in vivo situations.